Skip to main content

CME GROUP INC

For the period ended Sep 30, 2024. Filed Nov 8, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 8, 2024

CME$305.89-0.4%Stored close · as of Nov 6, 2026

What changed in Risk Factors?

Read the current filing

Previous report: 10-Q

Period ended 2024-06-30; filed 2024-08-05.

0001156375-24-000149

Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of Proceeds

Current report: 10-Q

Period ended 2024-09-30; filed 2024-11-08.

0001156375-24-000200

Item 1A. Risk FactorsUnregistered Sales of Equity Securities and Use of Proceeds

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 3 previous paragraphs and 3 current paragraphs.

2 unchanged; 1 reworded; 0 added; 0 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 3 previous and 3 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Reworded paragraphs (1)

Previous wording

(1)Shares purchased consist of an aggregate of 181 shares of Class A common stock surrendered in the second quarter of 2024 to satisfy employees’ tax obligations upon the vesting of restricted stock.

Current wording

(1)Shares purchased consist of an aggregate of 81,406 shares of Class A common stock surrendered in the third quarter of 2024 to satisfy employees’ tax obligations upon the vesting of restricted stock.